Elevance Health reports mixed Q4 results; initiates FY26 outlook
2026-01-28 06:04:20 ET
More on Elevance Health
- Elevance Health: The Potential Turnaround The Market Isn't Pricing In
- Elevance Health, Inc. (ELV) Presents at UBS Global Healthcare Conference 2025 Transcript
- Humana, other insurers fall on flat rates for Medicaid Advantage payments in 2027
- Obamacare enrollment shows faulty CBO forecast - WSJ Editorial Board
- Seeking Alpha’s Quant Rating on Elevance Health
Read the full article on Seeking Alpha
For further details see:
Elevance Health reports mixed Q4 results; initiates FY26 outlookNASDAQ: ELV
ELV Trading
1.36% G/L:
$397.66 Last:
917,418 Volume:
$396 Open:



